Last quarter (Q ), Lipella Pharmaceuticals, Inc.'s total revenue was $120.80K, a decrease of -20.00% from the same quarter last year. In Q, Lipella Pharmaceuticals, Inc.'s net income was $-688.90K. See Lipella Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 449.57K	$ 449.62K	$ 184.16K	$ 259.35K	$ 961.68K
Cost of Revenue	-	-	-	-	-
Gross Profit	$ 449.62K	$ 449.62K	$ 184.16K	-	-
Operating Expense	$ 5.20M	$ 5.20M	$ 2.77M	$ 2.18M	$ 1.02M
Operating Income	$ -4.75M	$ -4.75M	$ -2.59M	$ -1.92M	$ -56.86K
Net Non Operating Interest Income Expense	$ 126.99K	$ 126.99K	$ -7.93K	$ -6.73K	$ -4.79K
Other Income Expense	$ -143.82K	$ -143.82K	$ 45.00	$ 57.09K	-
Pretax Income	$ -4.62M	$ -4.62M	$ -2.60M	$ -1.87M	$ -61.66K
Tax Provision	-	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -2.21M	$ -4.62M	$ -2.60M	$ -1.87M	$ -61.66K
Basic EPS	$ -0.79	$ -0.77	$ -0.64	$ -0.33	$ -0.01
Diluted EPS	$ -0.79	$ -0.77	$ -0.64	$ -0.33	$ -0.01
Basic Average Shares	$ 24.01M	$ 6.00M	$ 4.06M	$ 5.74M	$ 5.74M
Diluted Average Shares	$ 24.01M	$ 6.00M	$ 4.06M	$ 5.74M	$ 5.74M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 5.20M	$ 5.20M	$ 2.77M	$ 2.18M	$ 1.02M
Net Income From Continuing And Discontinued Operation	$ -4.62M	$ -4.62M	$ -2.60M	$ -1.87M	$ -61.66K
Normalized Income	$ -2.81M	$ -3.65M	-	$ -1.87M	$ -61.66K
Interest Expense	-	-	-	$ 6.83K	$ 7.96K
EBIT	$ -4.61M	$ -4.61M	$ -2.59M	$ -1.86M	$ -53.69K
EBITDA	$ -4.61M	$ -4.61M	$ -2.59M	$ -1.86M	$ -53.69K

Currency in USD

Lipella Pharmaceuticals, Inc. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing